Country: Malaysia
Bahasa: Inggeris
Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
Ciprofloxacin Hydrochloride USP
UNIMED SDN BHD
Ciprofloxacin Hydrochloride USP
100Tablet Tablets
Unique Pharmaceuticals Laboratories (A Division Of J.B. Chemicals & Pharmaceuticals Ltd) (INDIA)
_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_ IFICIPRO 250/500 Ciprofloxacin Hydrochloride Tablet USP (250mg and 500mg) Fexofenadine Hydrochloride Tablets USP 180mg 1 WHAT IS IN THIS LEAFLET 1. What IFICIPRO is used for 2. How IFICIPRO works 3. Before you use IFICIPRO 4. How to use IFICIPRO 5. While you are using it 6. Side effects 7. Storage and Disposal of IFICIPRO 8. Product Description 9. Manufacturer and Product Registration Holder 10. Date of revision WHAT IFICIPRO IS USED FOR IFICIPRO can be used to treat or prevent certain infections caused by bacteria: Infections of the respiratory tract, urinary tract, gastrointestinal (GI), skin and soft tissues, bones and joints. Bacteria in the blood (Septicemia), inflammation of the inner wall of the abdomen (peritonitis), infection in patients with reduced immunity. HOW IFICIPRO WORKS Ificipro contains ciprofloxacin as active ingredient. It belongs to a group of antibiotics called fluoroquinolone. Antibiotics kill the bacteria or germ which causes infections. BEFORE YOU USE IFICIPRO _When you must not use it _ Do not take IFICIPRO if you: Ever had a history of hypersensitivity to ciprofloxacin, any member of the quinolone class of antimicrobial agents, or any of the product components. - _Before you start to use it _ • Tell your healthcare providers if you have been diagnosed with an enlargement or “bulge” of a large blood vessel (aortic aneurysm or large vessel peripheral aneurysm) • Tell your healthcare providers if you have experienced a previous episode of aortic dissection (a tear in the aorta wall) • Tell your healthcare providers if you have a family history of aortic aneurysm or aortic dissection or other risk factors or predisposing conditions (e.g., connective tissue disorders such as Marfan syndrome, or vascular Ehlers-Danlos syndrome, or vascular disorders such as Takayasu arteritis, giant cell arteritis, Behcet’s disease, high blood pressure, or known atherosclerosis. • You should not take fluoroquinolone antibacterial medicines, incl Baca dokumen lengkap
140 mm 220 mm Front For the use of Medical Practitioner or a Hospital or a Laboratory only IFICIPRO* 250/500 Ciprofloxacin Tablets USP 250 mg/500 mg COMPOSITION: Each film coated tablet contains: Ciprofloxacin Hydrochloride USP eq. to Ciprofloxacin 250mg / 500 mg. DESCRIPTION: lficipro 250mg tablets (Ciprofloxacin Tablets 250mg): White to yellowish white, round biconvex, film coated tablets. lficipro 500mg tablets (Ciprofloxacin Tablets 500mg): White to yellowish white, capsule shaped film coated tablets with break line on one side and other side plain. PHARMACODYNAMICS: Ciprofloxacin is from the quinolone group; these substances are also known as gyrase inhibitors. MICROBIOLOGY: GRAM-NEGATIVE ORGANISMS Enterobacteriaceae including _E.coli, Salmonella _ species _, Klebsiella _ species _, Shigel-_ _la, Proteus mirabilis, Proteus vulgaris, K. oxytoca, Yersinia enterocolitica, Entero-_ _bacter, Citrobacter, Morganella morganii, Pseudomonas aeruginosa, Hemophilus _ _Influenza, Acinetobacter, Campylobacter, Brucella melitensis, Pasteurella multo-_ _cida, Eikenella corrodenus, Flavobacterium, Moraxella, Gardenerella Vaginalis, _ _Legionells _ species _, Vibrio cholerae _ and _Vibrio parahernolyticus, Neisseria menin-_ _gitidis _ and _Neisseria gonorrhea _ including b-lactomase producing strains. GRAM-POSITIVE ORGANISMS _Staphylococcus aureus _ including _ b-lactamase _ producing and _ methicillin-resistant _ _strains, streptococcus pneumoniae group A 8-hemolytic streptococci, _ group B _ _ _streptococci _ and other _ streptococci, Enterococci including Enterococcus faecalis, _ _Corynebacterium _ and _Listeria monocytogenes._ OTHER MICROORGANISMS Anaerobic bacteria including _actinomyces, Bifidobacterium, Peptococcus, _ _Clostridium perfringens, Eubacterium, Propioribactirium acres_ , _Veiiionella_ and some strains of _Baderoides, Chlamydia, Mycoplasma and Mycobacterium_ . Ificip- ro is effective against organisms resistant to nalidixic acid. Since cross-resistance is unlikely, Ificipro may be used to treat infections c Baca dokumen lengkap